• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤微环境中,癌症干细胞衍生的细胞外囊泡优先靶向 MHC-II-巨噬细胞和 PD1+T 细胞。

Cancer stem cell-derived extracellular vesicles preferentially target MHC-II-macrophages and PD1+ T cells in the tumor microenvironment.

机构信息

Department of Cell, Developmental & Cancer Biology, Oregon Health and Science University, Portland, Oregon, United States of America.

Bionanoplasmonics Group, CIC biomaGUNE, Donostia-San Sebastián, Spain.

出版信息

PLoS One. 2023 Feb 3;18(2):e0279400. doi: 10.1371/journal.pone.0279400. eCollection 2023.

DOI:10.1371/journal.pone.0279400
PMID:36735677
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9897575/
Abstract

Immunotherapy is an approved treatment option for head and neck squamous cell carcinoma (HNSCC). However, the response rate to immune checkpoint blockade is only 13% for recurrent HNSCC, highlighting the urgent need to better understand tumor-immune interplay, with the ultimate goal of improving patient outcomes. HNSCC present high local recurrence rates and therapy resistance that can be attributed to the presence of cancer stem cells (CSC) within tumors. CSC exhibit singular properties that enable them to avoid immune detection and eradication. How CSC communicate with immune cells and which immune cell types are preferentially found within the CSC niche are still open questions. Here, we used genetic approaches to specifically label CSC-derived extracellular vesicles (EVs) and to perform Sortase-mediated in vivo proximity labeling of CSC niche cells. We identified specific immune cell subsets that were selectively targeted by EVCSC and that were found in the CSC niche. Native EVCSC preferentially targeted MHC-II-macrophages and PD1+ T cells in the tumor microenvironment, which were the same immune cell subsets enriched within the CSC niche. These observations indicate that the use of genetic technologies able to track EVs without in vitro isolation are a valuable tool to unveil the biology of native EVCSC.

摘要

免疫疗法是头颈部鳞状细胞癌(HNSCC)的一种已批准的治疗选择。然而,对于复发性 HNSCC,免疫检查点阻断的反应率仅为 13%,这突出表明迫切需要更好地了解肿瘤-免疫相互作用,最终目标是改善患者的预后。HNSCC 具有较高的局部复发率和治疗耐药性,这可归因于肿瘤内存在癌症干细胞(CSC)。CSC 表现出使其能够逃避免疫检测和清除的独特特性。CSC 如何与免疫细胞通信以及哪种免疫细胞类型优先存在于 CSC 龛位中,仍然是悬而未决的问题。在这里,我们使用遗传方法专门标记 CSC 衍生的细胞外囊泡(EV),并对 CSC 龛位细胞进行 Sortase 介导的体内邻近标记。我们鉴定了特定的免疫细胞亚群,这些细胞亚群被 EVCSC 选择性靶向,并且存在于 CSC 龛位中。天然 EVCSC 优先靶向肿瘤微环境中的 MHC-II-巨噬细胞和 PD1+T 细胞,这与 CSC 龛位中富集的相同免疫细胞亚群一致。这些观察结果表明,使用能够在不进行体外分离的情况下跟踪 EV 的遗传技术是揭示天然 EVCSC 生物学的有价值的工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0b7/9897575/d263e443edb7/pone.0279400.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0b7/9897575/fd63c11317a7/pone.0279400.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0b7/9897575/acd2d6783adc/pone.0279400.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0b7/9897575/978b12828de1/pone.0279400.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0b7/9897575/d263e443edb7/pone.0279400.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0b7/9897575/fd63c11317a7/pone.0279400.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0b7/9897575/acd2d6783adc/pone.0279400.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0b7/9897575/978b12828de1/pone.0279400.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0b7/9897575/d263e443edb7/pone.0279400.g004.jpg

相似文献

1
Cancer stem cell-derived extracellular vesicles preferentially target MHC-II-macrophages and PD1+ T cells in the tumor microenvironment.肿瘤微环境中,癌症干细胞衍生的细胞外囊泡优先靶向 MHC-II-巨噬细胞和 PD1+T 细胞。
PLoS One. 2023 Feb 3;18(2):e0279400. doi: 10.1371/journal.pone.0279400. eCollection 2023.
2
Heterogeneity of Head and Neck Squamous Cell Carcinoma Stem Cells.头颈部鳞状细胞癌干细胞的异质性。
Adv Exp Med Biol. 2019;1139:23-40. doi: 10.1007/978-3-030-14366-4_2.
3
Cancer Cell CD44 Mediates Macrophage/Monocyte-Driven Regulation of Head and Neck Cancer Stem Cells.肿瘤细胞 CD44 介导巨噬细胞/单核细胞对头颈部癌症干细胞的调控作用。
Cancer Res. 2020 Oct 1;80(19):4185-4198. doi: 10.1158/0008-5472.CAN-20-1079. Epub 2020 Aug 14.
4
5T4-Targeted Therapy Ablates Cancer Stem Cells and Prevents Recurrence of Head and Neck Squamous Cell Carcinoma.5T4靶向治疗可消除癌症干细胞并预防头颈部鳞状细胞癌复发。
Clin Cancer Res. 2017 May 15;23(10):2516-2527. doi: 10.1158/1078-0432.CCR-16-1834. Epub 2016 Oct 25.
5
MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro.微小RNA-34a在体外调节头颈部鳞状细胞癌的上皮-间质转化和癌症干细胞表型。
Int J Oncol. 2015 Oct;47(4):1339-50. doi: 10.3892/ijo.2015.3142. Epub 2015 Aug 31.
6
Tumor-derived extracellular vesicles in the immune microenvironment of head and neck squamous cell carcinoma: Foe or future?肿瘤衍生的细胞外囊泡在头颈部鳞状细胞癌免疫微环境中的作用:敌人还是未来?
J Stomatol Oral Maxillofac Surg. 2024 Sep;125(4):101738. doi: 10.1016/j.jormas.2023.101738. Epub 2023 Dec 12.
7
Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas.对头颈部鳞状细胞癌中具有干细胞特性的癌细胞进行鉴定、扩增及特性分析。
Exp Cell Res. 2016 Oct 15;348(1):75-86. doi: 10.1016/j.yexcr.2016.09.003. Epub 2016 Sep 9.
8
Elevated intrinsic cancer stem cell population in human papillomavirus-associated head and neck squamous cell carcinoma.人乳头瘤病毒相关性头颈部鳞状细胞癌中升高的固有癌症干细胞群体。
Cancer. 2014 Apr 1;120(7):992-1001. doi: 10.1002/cncr.28538. Epub 2013 Dec 30.
9
Association between cancer stem cell gene expression signatures and prognosis in head and neck squamous cell carcinoma.头颈部鳞状细胞癌中癌症干细胞基因表达特征与预后的相关性。
BMC Cancer. 2022 Oct 19;22(1):1077. doi: 10.1186/s12885-022-10184-4.
10
[The tumor stem cell niche of head and neck - point of intersection with therapeutic potential?].[头颈部肿瘤干细胞生态位——与治疗潜力的交汇点?]
Laryngorhinootologie. 2021 Jan;100(1):23-29. doi: 10.1055/a-1260-3054. Epub 2021 Jan 5.

引用本文的文献

1
Stem-Cell Niches in Health and Disease: Microenvironmental Determinants of Regeneration and Pathology.健康与疾病中的干细胞微环境:再生与病理学的微环境决定因素
Cells. 2025 Jun 26;14(13):981. doi: 10.3390/cells14130981.
2
Exosome crosstalk between cancer stem cells and tumor microenvironment: cancer progression and therapeutic strategies.肿瘤干细胞与肿瘤微环境间的外泌体串扰:癌症进展与治疗策略。
Stem Cell Res Ther. 2024 Nov 22;15(1):449. doi: 10.1186/s13287-024-04061-z.
3
Unlocking the Therapeutic Potential of Oral Cancer Stem Cell-Derived Exosomes.

本文引用的文献

1
Extracellular Vesicles from Pancreatic Cancer Stem Cells Lead an Intratumor Communication Network (EVNet) to fuel tumour progression.胰腺癌干细胞来源的细胞外囊泡构建肿瘤内通讯网络(EVNet)以促进肿瘤进展。
Gut. 2022 Jan 10;71(10):2043-68. doi: 10.1136/gutjnl-2021-324994.
2
Macrophage Polarization States in the Tumor Microenvironment.肿瘤微环境中的巨噬细胞极化状态。
Int J Mol Sci. 2021 Jun 29;22(13):6995. doi: 10.3390/ijms22136995.
3
Immune Cell Modulation of the Extracellular Matrix Contributes to the Pathogenesis of Pancreatic Cancer.
释放口腔癌干细胞衍生外泌体的治疗潜力
Biomedicines. 2024 Aug 9;12(8):1809. doi: 10.3390/biomedicines12081809.
4
A case for the study of native extracellular vesicles.一项关于天然细胞外囊泡的研究实例。
Front Oncol. 2024 Jul 12;14:1430971. doi: 10.3389/fonc.2024.1430971. eCollection 2024.
5
Modulatory effects of cancer stem cell-derived extracellular vesicles on the tumor immune microenvironment.肿瘤干细胞衍生的细胞外囊泡对肿瘤免疫微环境的调节作用。
Front Immunol. 2024 Jun 19;15:1362120. doi: 10.3389/fimmu.2024.1362120. eCollection 2024.
6
Sortase-mediated labeling: Expanding frontiers in site-specific protein functionalization opens new research avenues.Sortase 介导的标记:拓展定点蛋白质功能化的前沿,开辟新的研究途径。
Curr Opin Chem Biol. 2024 Jun;80:102443. doi: 10.1016/j.cbpa.2024.102443. Epub 2024 Mar 19.
7
Molecular panorama of therapy resistance in prostate cancer: a pre-clinical and bioinformatics analysis for clinical translation.前列腺癌治疗耐药性的分子全景:临床转化的临床前和生物信息学分析。
Cancer Metastasis Rev. 2024 Mar;43(1):229-260. doi: 10.1007/s10555-024-10168-9. Epub 2024 Feb 19.
8
Targeting cancer stem cells as a strategy for reducing chemotherapy resistance in head and neck cancers.以癌症干细胞为靶点作为降低头颈癌化疗耐药性的一种策略。
J Cancer Res Clin Oncol. 2023 Nov;149(14):13417-13435. doi: 10.1007/s00432-023-05136-9. Epub 2023 Jul 15.
9
Exosomes, microvesicles, and other extracellular vesicles-a Keystone Symposia report.外泌体、微泡和其他细胞外囊泡——一个基石研讨会报告。
Ann N Y Acad Sci. 2023 May;1523(1):24-37. doi: 10.1111/nyas.14974. Epub 2023 Mar 18.
免疫细胞对细胞外基质的调节作用有助于胰腺癌的发病机制。
Biomolecules. 2021 Jun 17;11(6):901. doi: 10.3390/biom11060901.
4
Extracellular vesicles in immunomodulation and tumor progression.细胞外囊泡在免疫调节和肿瘤进展中的作用。
Nat Immunol. 2021 May;22(5):560-570. doi: 10.1038/s41590-021-00899-0. Epub 2021 Mar 22.
5
Tumor microenvironment in head and neck squamous cell carcinoma: Functions and regulatory mechanisms.头颈部鳞状细胞癌中的肿瘤微环境:功能与调控机制
Cancer Lett. 2021 Jun 1;507:55-69. doi: 10.1016/j.canlet.2021.03.009. Epub 2021 Mar 17.
6
Macrophages and Extracellular Matrix in Breast Cancer: Partners in Crime or Protective Allies?乳腺癌中的巨噬细胞与细胞外基质:是犯罪同伙还是保护盟友?
Front Oncol. 2021 Feb 24;11:620773. doi: 10.3389/fonc.2021.620773. eCollection 2021.
7
Extracellular Vesicles in Oncology: from Immune Suppression to Immunotherapy.肿瘤学中的细胞外囊泡:从免疫抑制到免疫治疗。
AAPS J. 2021 Feb 14;23(2):30. doi: 10.1208/s12248-021-00554-4.
8
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
9
Extracellular vesicles shed from gastric cancer mediate protumor macrophage differentiation.从胃癌中释放的细胞外囊泡介导促肿瘤巨噬细胞分化。
BMC Cancer. 2021 Jan 28;21(1):102. doi: 10.1186/s12885-021-07816-6.
10
Cancer Stemness Meets Immunity: From Mechanism to Therapy.癌症干性与免疫:从机制到治疗。
Cell Rep. 2021 Jan 5;34(1):108597. doi: 10.1016/j.celrep.2020.108597.